Ameren has cleared its Q1 print and the positioning picture has shifted — short sellers are pulling back, options traders have turned calmer, and a clutch of peers are outperforming on the week.
The short-interest story is the clearest change from a week ago. SI fell 4% over the past five sessions to 3.6% of free float, reversing a build that had pushed borrowed shares to a month-to-date high of roughly 10.1 million around May 11. That peak aligns with the pre-earnings uncertainty described in last week's note, and the subsequent unwind suggests at least some of that positioning was event-driven rather than a structural bear thesis. The month-on-month picture still shows an 8.9% rise in shares short, so the trend bears watching, but the immediate post-earnings direction is lower. Borrow remains extremely accessible — availability is running at roughly 4,472%, far above the 52-week floor of 869%, and cost to borrow is just 0.51% APR. There is no squeeze pressure here.
Options positioning has also normalised after the pronounced call skew heading into Q1. The put/call ratio now runs at 0.28, just modestly above its 20-day average of 0.26 and only 0.36 standard deviations above the mean. That is a far cry from the defensive spikes seen in mid-April when the PCR briefly touched 0.75. The read: options traders are neither hedging aggressively nor pressing calls — the market has digested the earnings result and moved back toward a neutral stance.
The Street's reaction to Q1 has been a round of modest target cuts without any change in conviction. Truist Securities trimmed its target from $126 to $121 this week while holding its Buy. JP Morgan followed last week, cutting from $123 to $120 on a Neutral. Morgan Stanley lowered to $117, also maintaining Equal-Weight. The direction of travel is uniformly lower on targets, but no firm has downgraded — and the mean consensus target at $119.87 still sits roughly 10% above the current $109 price. Bulls point to a 3% retail sales volume increase at Ameren Missouri and improving regulated utility fundamentals. Bears flag dilution risk from ~5.8 million shares tied to forward sale agreements and the modest near-term earnings boost from the Missouri rate case. The earnings yield factor scores in the 71st percentile for EPS surprise, and the dividend score is a standout at the 97th percentile — income-focused holders have little reason to move.
Peer performance underlines that Ameren's modest weekly decline of 0.4% is more idiosyncratic than sector-driven. CNP gained 0.9% on the week, ED added 1.2%, and D surged 8.3%. Even WEC, Ameren's closest peer by correlation, only fell 0.97%. The post-Q1 print of -2.5% on May 14 is consistent with recent earnings history — each of the last two releases produced a next-day decline in the 2.5% range, pointing to a pattern of mild disappointment on results day even against a broadly constructive fundamental backdrop.
With Q2 results now pencilled for July 31, the next few weeks are likely to centre on whether the Missouri rate case contribution ramps as guided and whether the stock can close some of the gap to peers that have been quietly outperforming since the print.
See the live data behind this article on ORTEX.
Open AEE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
